Mustafa Nevzat İlaç, which has been serving for public health for nearly a century, was acquired by Amgen Biotechnology in 2012. In 2020, Mustafa Nevzat İlaç has been taken the name of Gensenta. Subsequently, Gensenta which facilitated patients' access to medicines with its efforts to offer new and comprehensive solutions to more patients in a wider geography continues its activities as one of the Eczacıbaşı Group establishments in November 2022.
There are four separate production units of the Active Pharmaceutical Ingredients Plant; penicillin group active substances, macrolide group active substances and etodolac, and other active substances are manufactured. In Production Plant I, penicillin group antibiotics like Sulbactam Sodium, Sultamicillin Tosylate and Sultamicillin Base are manufactured. In Production Plant II, Etodolac, Voriconazole and macrolide group antibiotics like Clarithromycin granules are manufactured. In Production Plant III and Plant IV productions of 1-500 kg capacities take place; in this Pilot and Small Scale Production Plants, active substances like Granisetron, Zoledronic Acid, Rocuronium Bromide, Aripiprazole, Monosodium Ibandronate Monohydrate and Imatinib Mesylate are manufactured.
There are four dedicated production plants for finished dosage forms in Yenibosna, İstanbul; all basic forms of pharmaceuticals, including injectables such as liquid and freeze-dried ampoules and vials, sterile powder vials and oral dosage forms such as hard gelatin capsules, tablets, film-coated tablets and dry powder suspensions are produced in Yenibosna.
The products are manufactured according to 'Current Good Manufacturing Practices (cGMP)' and 'Current Good Laboratory Practices (cGLP)' and as a result of continuous training, education and modern technology; the products are used by patients both in Turkey and in various countries abroad.
In July 2004, Gensenta received EU-GMP certificate from Germany for the ampicillin sodium / sulbactam sodium for injection. This certificate has been renewed following the inspections in 2007 and 2009.
Our vision is to continue and expand our leading role into international arena in creating the “firsts” of the national pharmaceutical industry, sustain and continue to be the preferred company for our business partners and employees in reference of trust.
Our mission is to serve national and international community to provide a healthier and happier life by producing high quality and cost-effective medicines.